Date:8/11/2008

d uncertainties, which may cause Thermage's actual results to differ materially from the statements contained herein including but not limited to market acceptance and demand of current and future products among physicians and patients, our ability to successfully integrate the operations of Reliant and realize synergies, the potential impact of general economic conditions on the demand for our products, risks inherent with third-party supply and distribution networks, risks inherent to future sales growth, and the ability to execute proposed initiatives. Further information on potential risk factors that could affect Thermage's business and its financial results are detailed in its Form 10-K for the year ended December 31, 2007, its Form 10-Q for the quarter ended March 31, 2008 and other reports as filed from time to time with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Thermage undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Thermage, Inc.

NON-GAAP RECONCILIATION OF

NET INCOME PER SHARE

(unaudited)

Range of Estimates

From To

2008 GAAP diluted net income per share (a) $0.00 $0.03

Stock-based compensation (b) 0.18 0.18

2008 Non-GAAP diluted net income per share (a) $0.18 $0.21

(a) Reflects weighted average outstanding used in calculating diluted net

income per share of 26 million.

(b) Represents the Company's estimate of stock-based compensation

charges, net of ta
'/>"/>

SOURCE Thermage, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. Thermage, Inc. to Present at the Maxim Group Growth Conference
2. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
3. Thermage Announces Third Quarter Financial Results
4. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
5. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
6. Thermage Announces Fourth Quarter and Full Year 2007 Financial Results
7. Thermage, Inc. Announces Initial Shipments of Cellulite Product
8. Thermage, Inc. Announces First Quarter 2008 Results Release Date and Conference Call
9. Thermage, a Leading Aesthetic Medical Device Company, Announces First Time Exhibitor Status at ACOG Meeting
10. Thermage, Inc. to Present at the Bank of America 2008 Healthcare Conference
11. Thermage and Reliant Technologies to Join Forces